相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Sensitivity Mapping of Cortical Dopamine D2 Receptor Expressing Neurons
Jivan Khlghatyan et al.
CEREBRAL CORTEX (2019)
CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior
J. Castello et al.
MOLECULAR PSYCHIATRY (2018)
The daunting polygenicity of mental illness: making a new map
Steven E. Hyman
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission
Jivan Khlghatyan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes
Jiang Li et al.
SCHIZOPHRENIA RESEARCH (2018)
Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
Jivan Khlghatyan et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2018)
Reduced levels of Cacna1c attenuate mesolimbic dopamine system function
C. E. Terrillion et al.
GENES BRAIN AND BEHAVIOR (2017)
The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders
Alexandre Bureau et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci
Atsushi Takata et al.
NATURE COMMUNICATIONS (2017)
Association of functional genetic variation in PP2A with prefrontal working memory processing
Antonio Rampino et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia
Ganna Leonenko et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects
Thelma Beatriz Gonzalez-Castro et al.
NEUROMOLECULAR MEDICINE (2016)
Tracking the Fragile X Mental Retardation Protein in a Highly Ordered Neuronal RiboNucleoParticles Population: A Link between Stalled Polyribosomes and RNA Granules
Rachid El Fatimy et al.
PLOS GENETICS (2016)
Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
J. M. Stevenson et al.
TRANSLATIONAL PSYCHIATRY (2016)
Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach
Douglas M. Ruderfer et al.
LANCET PSYCHIATRY (2016)
A multi-omic analysis of human naive CD4+T cells
Christopher J. Mitchell et al.
BMC SYSTEMS BIOLOGY (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers
Thomas Del' Guidice et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients (vol 20, pg 150, 2015)
J. Frank et al.
MOLECULAR PSYCHIATRY (2015)
FXR1P is a GSK3β substrate regulating mood and emotion processing
Thomas Del'Guidice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Association of GRIN1, ABCB1, and DRD4 genes and response to antipsychotic drug treatment in schizophrenia
Pranita Pai et al.
PSYCHIATRIC GENETICS (2015)
Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis
Jian-Ping Zhang et al.
SCHIZOPHRENIA BULLETIN (2015)
Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders
Timothy D. Folsom et al.
SCHIZOPHRENIA RESEARCH (2015)
Dysfunctional HCN ion channels in neurological diseases
Jacopo C. DiFrancesco et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Dopamine receptors - IUPHAR Review 13
Jean-Martin Beaulieu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Loss of neuronal GSK3 beta reduces dendritic spine stability and attenuates excitatory synaptic transmission via beta-catenin
S. M. Ochs et al.
MOLECULAR PSYCHIATRY (2015)
Treatment-resistant schizophrenia and DAT and SERT polymorphisms
Petar Bilic et al.
GENE (2014)
Polymorphisms in the Dopamine Receptor 2 Gene Region Influence Improvements during Working Memory Training in Children and Adolescents
Stina Soderqvist et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Genome-scale neurogenetics: methodology and meaning
Steven A. McCarro et al.
NATURE NEUROSCIENCE (2014)
Subcellular Fractionation and Localization Studies Reveal a Direct Interaction of the Fragile X Mental Retardation Protein (FMRP) with Nucleolin
Mohamed S. Taha et al.
PLOS ONE (2014)
FXR1P Limits Long-Term Memory, Long-Lasting Synaptic Potentiation, and De Novo GluA2 Translation
Denise Cook et al.
CELL REPORTS (2014)
Association of GSK-3β Genetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia
Giuseppe Blasi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability
Ingo Vernaleken et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
D1 Dopamine Receptor Coupling to PLCβ Regulates Forward Locomotion in Mice
Ivan O. Medvedev et al.
JOURNAL OF NEUROSCIENCE (2013)
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Michael R. Santoro et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 2: Clinical Studies Using Atypical Antipsychotics, Anticonvulsants, and Lithium
Stefano Comai et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
CNS Dopamine Transmission Mediated by Noradrenergic Innervation
Caroline C. Smith et al.
JOURNAL OF NEUROSCIENCE (2012)
FMRP targets distinct mRNA sequence elements to regulate protein expression
Manuel Ascano et al.
NATURE (2012)
Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action
Nikhil M. Urs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Jennifer C. Darnell et al.
CELL (2011)
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
Jian-Ping Zhang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
J. L. McClay et al.
MOLECULAR PSYCHIATRY (2011)
Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
Joseph L. McClay et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia
Giuseppe Blasi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
D2 Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
Jian-Ping Zhang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance
Alessandro Bertolino et al.
PLOS ONE (2010)
Structural Studies of the Tandem Tudor Domains of Fragile X Mental Retardation Related Proteins FXR1 and FXR2
Melanie A. Adams-Cioaba et al.
PLOS ONE (2010)
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Louis M. Luttrell et al.
PHARMACOLOGICAL REVIEWS (2010)
Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
Mingqing Xu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Jean-Martin Beaulieu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia
Alessandro Bertolino et al.
BRAIN (2009)
Getting specialized: presynaptic and postsynaptic dopamine D2 receptors
Claudia De Mei et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia
Simona Volpi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Altered Hippocampal Synaptic Plasticity in the Fmr1 Gene Family Knockout Mouse Models
Jing Zhang et al.
JOURNAL OF NEUROPHYSIOLOGY (2009)
Functional Variation of the Dopamine D2 Receptor Gene Is Associated with Emotional Control as well as Brain Activity and Connectivity during Emotion Processing in Humans
Giuseppe Blasi et al.
JOURNAL OF NEUROSCIENCE (2009)
Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients
Yu-Chih Shen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study
C. Lavedan et al.
MOLECULAR PSYCHIATRY (2009)
Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms
M. Gupta et al.
PHARMACOGENOMICS (2009)
Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment
Meenal Gupta et al.
PHARMACOGENOMICS (2009)
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
B. A. Fijal et al.
PHARMACOGENOMICS JOURNAL (2009)
Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors
Shih-Fen Chen et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective
David H. Adams et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
Nicole C. Allen et al.
NATURE GENETICS (2008)
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
Masashi Ikeda et al.
PHARMACOGENOMICS (2008)
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
Philip McGuire et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory
Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders:: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment
P. Molero et al.
PHARMACOGENOMICS JOURNAL (2007)
Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects
Xavier Caldu et al.
NEUROIMAGE (2007)
COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia
Neil D. Woodward et al.
SCHIZOPHRENIA RESEARCH (2007)
COMT Val(158) Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia
Alessandro Bertolino et al.
SCHIZOPHRENIA RESEARCH (2007)
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor
Freddy Jeanneteau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain
A Bertolino et al.
JOURNAL OF NEUROSCIENCE (2006)
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers
CE Johanson et al.
PSYCHOPHARMACOLOGY (2006)
The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia:: Evidence from fixed- and random-effects meta-analyses
SJ Glatt et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
The dopaminergic midbrain participates in human episodic memory formation:: Evidence from genetic imaging
BH Schott et al.
JOURNAL OF NEUROSCIENCE (2006)
The variable number of tandem repeats element in DATI regulates in vitro dopamine transporter density -: art. no. 55
SH VanNess et al.
BMC GENETICS (2005)
Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine
AL Zhao et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations
R Hwang et al.
PSYCHOPHARMACOLOGY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample
KM Cornish et al.
MOLECULAR PSYCHIATRY (2005)
Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients
SN Wu et al.
NEUROSCIENCE LETTERS (2005)
Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics
S Anttila et al.
PHARMACOGENETICS (2004)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Catecholamine metabolism: A contemporary view with implications for physiology and medicine
G Eisenhofer et al.
PHARMACOLOGICAL REVIEWS (2004)
Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal
SP Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
HY Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Desensitization of G protein-coupled receptors and neuronal functions
RR Gainetdinov et al.
ANNUAL REVIEW OF NEUROSCIENCE (2004)
Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia
A Illi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice
RR Gainetdinov et al.
NEURON (2003)
Association study between dopamine D3 receptor gene variant and personality traits
EG Jönsson et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
JB Duan et al.
HUMAN MOLECULAR GENETICS (2003)
Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR:: Evidence from brain and lymphocytes using quantitative RT-PCR
J Mill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Assessing the molecular genetics of attention networks
John Fossella et al.
BMC NEUROSCIENCE (2002)
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter:: Evidence from knock-out mouse lines
JA Morón et al.
JOURNAL OF NEUROSCIENCE (2002)
Comparative genomic sequence analysis of the FXR gene family:: FMR1, FXR1, and FXR2
LL Kirkpatrick et al.
GENOMICS (2001)
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function
JC Darnell et al.
CELL (2001)
Developmental expression of the fragile X-related 1 proteins in mouse testis: association with microtubule elements
ME Huot et al.
HUMAN MOLECULAR GENETICS (2001)
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D2 receptor gene
M Schäfer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Olanzapine: concordant response in monozygotic twins with schizophrenia
I Mata et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins
F Tamanini et al.
HUMAN MOLECULAR GENETICS (2000)
The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients
A Suzuki et al.
PHARMACOGENETICS (2000)
Genotype influences in vivo dopamine transporter availability in human striatum
A Heinz et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
